Renovation of the injured heart with myocardial tissue engineering

References

• Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354(Suppl. 1), SI32–SI34 (1999).
   Google Scholar
• Sun Y, Kiani MF, Postlethwaite AE, Weber KT. Infarct scar as living tissue. Basic Res. Cardiol. 97, 343–347 (2002).
   PubMed Web of Science ®Google Scholar
• Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94, 1543–1553 (2004).
   PubMed Web of Science ®Google Scholar
• Ertl G, Frantz S. Wound model of myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 288, H981–H983 (2005).
   Web of Science ®Google Scholar
• Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108, 1395–403 (2003).
   PubMed Web of Science ®Google Scholar
• Etzion S, Kedes LH, Kloner RA, Leor J. Myocardial regeneration: present and future trends. Am. J. Cardiovasc. Drugs 1, 233–244 (2001).
   PubMedGoogle Scholar
• Laflamme MA, Murry CE. Regenerating the heart. Nature Biotechnol. 23, 845–856 (2005).
   PubMed Web of Science ®Google Scholar
• Leor J, Barbash IM. Cell transplantation and genetic engineering: new approaches to cardiac pathology. Expert Opin. Biol. Ther. 3, 1023–1039 (2003).
   PubMed Web of Science ®Google Scholar
• Lee MS, Makkar RR. Stem-cell transplantation in myocardial infarction: a status report. Ann. Intern. Med. 140, 729–737 (2004).
   PubMed Web of Science ®Google Scholar
• Minatoguchi S, Takemura G, Chen XH et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109, 2572–2580 (2004).
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697–703 (2003).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763–776 (2003).
   PubMed Web of Science ®Google Scholar
• Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100, 12313–12318 (2003).
   PubMed Web of Science ®Google Scholar
• Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 279, 11384–11391 (2004).
   PubMed Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911–921 (2004).
   PubMed Web of Science ®Google Scholar
• Dow J, Simkhovich BZ, Kedes L, Kloner RA. Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovasc. Res. 67, 301–307 (2005).
   PubMed Web of Science ®Google Scholar
• Reinecke H, Murry CE. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J. Mol. Cell. Cardiol. 34, 251–253 (2002).
   PubMed Web of Science ®Google Scholar
• Etzion S, Battler A, Barbash IM et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J. Mol. Cell. Cardiol. 33, 1321–1330 (2001).
   PubMed Web of Science ®Google Scholar
• Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT. Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 97, 8–15 (2005).
   PubMed Web of Science ®Google Scholar
• Rabkin E, Schoen FJ. Cardiovascular tissue engineering. Cardiovasc. Pathol. 11, 305–317 (2002).
   PubMed Web of Science ®Google Scholar
• Kellar RS, Landeen LK, Shepherd BR, Naughton GK, Ratcliffe A, Williams SK. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation 104, 2063–2068 (2001).
   PubMed Web of Science ®Google Scholar
• Kelley ST, Malekan R, Gorman JH 3rd et al. Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation 99, 135–142 (1999).
   PubMed Web of Science ®Google Scholar
• Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM. Survival and function of bioengineered cardiac grafts. Circulation 100, II63–II69 (1999).
   PubMed Web of Science ®Google Scholar
• Ozawa T, Mickle DA, Weisel RD, Koyama N, Ozawa S, Li RK. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106, I176–I182 (2002).
   PubMed Web of Science ®Google Scholar
• Hench LL, Polak JM. Third-generation biomedical materials. Science 295, 1014–1017 (2002).
   PubMed Web of Science ®Google Scholar
• Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 428, 487–492 (2004).
   PubMed Web of Science ®Google Scholar
• Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 24, 4353–4364 (2003).
   PubMed Web of Science ®Google Scholar
• Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnol. 23, 47–55 (2005).
   PubMed Web of Science ®Google Scholar
• Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J. Cell. Biol. 103, 2637–2647 (1986).
   PubMed Web of Science ®Google Scholar
• Griffith LG, Lopina S. Microdistribution of substratum-bound ligands affects cell function: hepatocyte spreading on PEO-tethered galactose. Biomaterials 19, 979–986 (1998).
   PubMed Web of Science ®Google Scholar
• Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45–53 (1999).
   PubMed Web of Science ®Google Scholar
• Tiwari A, Salacinski HJ, Punshon G, Hamilton G, Seifalian AM. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J.16,791–796 (2002).
   PubMed Web of Science ®Google Scholar
• Pratt AB, Weber FE, Schmoekel HG, Muller R, Hubbell JA. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol. Bioeng. 86, 27–36 (2004).
   PubMed Web of Science ®Google Scholar
• Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem. Biophys. Res. Commun. 311, 179–186 (2003).
   PubMed Web of Science ®Google Scholar
• Koo LY, Irvine DJ, Mayes AM, Lauffenburger DA, Griffith LG. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J. Cell. Sci. 115, 1423–1433 (2002).
   PubMed Web of Science ®Google Scholar
• Kim MR, Jeong JH, Park TG. Swelling induced detachment of chondrocytes using RGD-modified poly(N-isopropylacrylamide) hydrogel beads. Biotechnol. Prog. 18, 495–500 (2002).
   PubMed Web of Science ®Google Scholar
• Mann BK, West JL. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J. Biomed. Mater. Res. 60, 86–93 (2002).
   PubMed Web of Science ®Google Scholar
• Halstenberg S, Panitch A, Rizzi S, Hall H, Hubbell JA. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules 3, 710–723 (2002).
   PubMed Web of Science ®Google Scholar
• Lee KY, Peters MC, Anderson KW, Mooney DJ. Controlled growth factor release from synthetic extracellular matrices. Nature 408, 998–1000 (2000).
   PubMed Web of Science ®Google Scholar
• Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407–414 (2001).
   PubMed Web of Science ®Google Scholar
• Swijnenburg RJ, Tanaka M, Vogel H et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112, I166–I172 (2005).
   Web of Science ®Google Scholar
• Scheubel RJ, Zorn H, Silber RE et al. Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 42, 2073–2080 (2003).
   PubMed Web of Science ®Google Scholar
• Rauscher FM, Goldschmidt-Clermont PJ, Davis BH et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108, 457–463 (2003).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Vasa-Nicotera M. Aging of progenitor cells: limitation for regenerative capacity? J. Am. Coll. Cardiol. 42, 2081–2082 (2003).
   PubMed Web of Science ®Google Scholar
• Menasche P. Cellular transplantation: hurdles remaining before widespread clinical use. Curr. Opin. Cardiol. 19, 154–161 (2004).
   PubMed Web of Science ®Google Scholar
• Smits PC, van Geuns RJ, Poldermans D et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. Clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42, 2063–2069 (2003).
   PubMed Web of Science ®Google Scholar
• Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109, 3154–3157 (2004).
   PubMed Web of Science ®Google Scholar
• Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363, 783–784 (2004).
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
   PubMed Web of Science ®Google Scholar
• Mummery C, Ward-Van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733–2740 (2003).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Lord B, Schulze PC et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107, 1912–1916 (2003).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25, 1639–1647 (2004).
   PubMed Web of Science ®Google Scholar
• Leor J, Cohen S. Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann. NY Acad. Sci. 1015, 312–319 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen S, Leor J. Rebuilding broken hearts. Biologists and engineers working together in the fledgling field of tissue engineering are within reach of one of their greatest goals: constructing a living human heart patch. Sci. Am. 291, 44–51 (2004).
   PubMedGoogle Scholar
• Eschenhagen T, Fink C, Remmers U et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J.11,683–694 (1997).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Didie M, Wasmeier GH et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106, I151–I157 (2002).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Schneiderbanger K, Schubert P et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90, 223–30 (2002).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Yamato M, Isoi Y et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90, e40 (2002).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Yamato M, Akutsu T et al. Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J. Biomed. Mater. Res. 60, 110–117 (2002).
   PubMed Web of Science ®Google Scholar
• Dar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol. Bioeng. 80, 305–312 (2002).
   PubMed Web of Science ®Google Scholar
• Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng. 8, 175–188 (2002).
   PubMedGoogle Scholar
• Papadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol. 280, H168–H178 (2001).
   PubMed Web of Science ®Google Scholar
• Carrier RL, Papadaki M, Rupnick M et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 64, 580–589 (1999).
   PubMed Web of Science ®Google Scholar
• Bursac N, Papadaki M, Cohen RJ et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 277, H433–H444 (1999).
   PubMedGoogle Scholar
• Akins RE, Boyce RA, Madonna ML et al. Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng. 5, 103–118 (1999).
   PubMedGoogle Scholar
• Bursac N, Papadaki M, White JA, Eisenberg SR, Vunjak-Novakovic G, Freed LE. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng. 9, 1243–1253 (2003).
   PubMedGoogle Scholar
• Kofidis T, Lenz A, Boublik J et al. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials 24, 5009–5014 (2003).
   PubMed Web of Science ®Google Scholar
• Kofidis T, Akhyari P, Boublik J et al. In vitro engineering of heart muscle: artificial myocardial tissue. J. Thorac. Cardiovasc. Surg. 124, 63–69 (2002).
   PubMed Web of Science ®Google Scholar
• Radisic M, Park H, Shing H et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. PNAS 0407817101 (2004).
   PubMedGoogle Scholar
• Radisic M, Yang L, Boublik J et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 286, H507–H516 (2004).
   PubMed Web of Science ®Google Scholar
• Leor J, Aboulafia-Etzion S, Dar A et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102, III56–III61 (2000).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68, 106–114 (2000).
   PubMed Web of Science ®Google Scholar
• Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 8, 259–269 (2003).
   PubMed Web of Science ®Google Scholar
• Fink C, Ergun S, Kralisch D, Remmers U, Weil J, Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J.14,669–679 (2000).
   PubMed Web of Science ®Google Scholar
• Mironov V, Boland T, Trusk T, Forgacs G, Markwald RR. Organ printing: computer-aided jet-based 3D tissue engineering. Trends Biotechnol. 21, 157–161 (2003).
   PubMed Web of Science ®Google Scholar
• McDevitt TC, Angello JC, Whitney ML et al. In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J. Biomed. Mater. Res. 60, 472–479 (2002).
   PubMed Web of Science ®Google Scholar
• McDevitt TC, Woodhouse KA, Hauschka SD, Murry CE, Stayton PS. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J. Biomed. Mater. Res. 66A, 586–595 (2003).
   Web of Science ®Google Scholar
• Papadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am. J. Physiol. Heart Circ. Physiol. 280, H168–H178 (2001).
   PubMed Web of Science ®Google Scholar
• Akhyari P, Fedak PW, Weisel RD et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106, I137–I142 (2002).
   PubMed Web of Science ®Google Scholar
• Gonen-Wadmany M, Gepstein L, Seliktar D. Controlling the cellular organization of tissue-engineered cardiac constructs. Ann. NY Acad. Sci. 1015, 299–311 (2004).
   PubMed Web of Science ®Google Scholar
• Colton CK. Implantable biohybrid artificial organs. Cell Transplant 4, 415–436 (1995).
   PubMed Web of Science ®Google Scholar
• Zandonella C. Tissue engineering: the beat goes on. Nature 421, 884–886 (2003).
   PubMed Web of Science ®Google Scholar
• Sodian R, Sperling JS, Martin DP et al. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng. 6, 183–188 (2000).
   PubMedGoogle Scholar
• Dohmen PM, Ozaki S, Verbeken E, Yperman J, Flameng W, Konertz WF. Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovasc. Thorac. Ann. 10, 25–30 (2002).
   PubMedGoogle Scholar
• Krupnick AS, Kreisel D, Engels FH et al. A novel small animal model of left ventricular tissue engineering. J. Heart Lung Transplant. 21, 233–243 (2002).
   PubMed Web of Science ®Google Scholar
• Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, Li RK. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 108(Suppl. 1), II219–II225 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33, 907–921 (2001).
   PubMed Web of Science ®Google Scholar
• Patel ZS, Mikos AG. Angiogenesis with biomaterial-based drug- and cell-delivery systems. J. Biomater. Sci. Polym. Ed. 15, 701–726 (2004).
   PubMed Web of Science ®Google Scholar
• Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109, 2692–2697 (2004).
   PubMed Web of Science ®Google Scholar
• Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part I: angiogenic cytokines. Circulation 109, 2487–2491 (2004).
   PubMed Web of Science ®Google Scholar
• Epstein SE, Kornowski R, Fuchs S, Dvorak HF. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115–119 (2001).
   PubMed Web of Science ®Google Scholar
• Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nature Biotechnol. 19, 1029–1034 (2001).
   PubMed Web of Science ®Google Scholar
• Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J. Biomed. Mater. Res. 65A, 489–497 (2003).
   Web of Science ®Google Scholar
• Peters MC, Isenberg BC, Rowley JA, Mooney DJ. Release from alginate enhances the biological activity of vascular endothelial growth factor. J. Biomater. Sci. Polym. Ed. 9, 1267–1278 (1998).
   PubMed Web of Science ®Google Scholar
• Hench LL, Xynos ID, Polak JM. Bioactive glasses for in situ tissue regeneration. J. Biomater. Sci. Polym. Ed. 15, 543–562 (2004).
   PubMed Web of Science ®Google Scholar
• Narmoneva DA, Vukmirovic R, Davis ME, Kamm RD, Lee RT. Endothelial cells promote cardiac myocyte ssurvival and spatial reorganization. Implications for Cardiac Regeneration. Circulation 01.CIR.0000140667.37070.07 (2004).
   PubMedGoogle Scholar
• Park HJ, Yoo JJ, Kershen RT, Moreland R, Atala A. Reconstitution of human corporal smooth muscle and endothelial cells in vivo. J. Urol. 162, 1106–1109 (1999).
   PubMed Web of Science ®Google Scholar
• Epstein SE, Stabile E, Kinnaird T, Lee CW, Clavijo L, Burnett MS. Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation 109, 2826–2831 (2004).
   PubMed Web of Science ®Google Scholar
• Davis ME, Motion JP, Narmoneva DA et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111, 442–450 (2005).
   PubMed Web of Science ®Google Scholar
• Elisseeff J. Injectable cartilage tissue engineering. Expert Opin. Biol. Ther. 4, 1849–1859 (2004).
   PubMed Web of Science ®Google Scholar
• Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 10, 403–409 (2004).
   PubMedGoogle Scholar
• Bootle-Wilbraham CA, Tazzyman S, Thompson WD, Stirk CM, Lewis CE. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4, 269–275 (2001).
   PubMedGoogle Scholar
• van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann. NY Acad. Sci. 936, 426–437 (2001).
   PubMed Web of Science ®Google Scholar
• Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44, 654–660 (2004).
   PubMed Web of Science ®Google Scholar
• Ryu JH, Kim IK, Cho SW et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26, 319–326 (2005).
   PubMed Web of Science ®Google Scholar
• Kofidis T, De Bruin JL, Hoyt G et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J. Thorac. Cardiovasc. Surg. 128, 571–578 (2004).
   PubMed Web of Science ®Google Scholar
• Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112, I173–I177 (2005).
   Google Scholar
• Dai W, Wold LE, Dow JS, Kloner RA. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J. Am. Coll. Cardiol. 46, 714–719 (2005).
   PubMed Web of Science ®Google Scholar
• Anversa P, Sussman MA, Bolli R. Molecular genetic advances in cardiovascular medicine: focus on the myocyte. Circulation 109, 2832–2838 (2004).
   PubMed Web of Science ®Google Scholar
• Kamelger FS, Marksteiner R, Margreiter E et al. A comparative study of three different biomaterials in the engineering of skeletal muscle using a rat animal model. Biomaterials 25, 1649–1655 (2004).
   PubMed Web of Science ®Google Scholar
• Li RK. Cell transplantation to improve heart function: cell or matrix. Yonsei Med. J. 45(Suppl.), S72–S73 (2004).
   PubMedGoogle Scholar
• Wu X, Rabkin-Aikawa E, Guleserian KJ et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 287, H480–H487 (2004).
   PubMed Web of Science ®Google Scholar
• Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45–46 (2003).
   PubMed Web of Science ®Google Scholar
• Krupnick AS, Kreisel D, Szeto WY, Popma SH, Rosengard BR. A murine model of left ventricular tissue engineering. J. Heart Lung Transplant. 20. 197–198 (2001).
   PubMedGoogle Scholar
• Kadner A, Zund G, Maurus C et al. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study. Eur. J. Cardiothorac. Surg. 25, 635–641 (2004).
   PubMed Web of Science ®Google Scholar
• Li RK, Yau TM, Weisel RD et al. Construction of a bioengineered cardiac graft. J. Thorac. Cardiovasc. Surg. 119, 368–375 (2000).
   PubMed Web of Science ®Google Scholar
• Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nature Biotechnol. 22, 1282–1289 (2004).
   PubMed Web of Science ®Google Scholar
• Lanza R, Moore MA, Wakayama T et al. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ. Res. 94, 820–827 (2004).
   PubMed Web of Science ®Google Scholar
• Chandy T, Rao GH, Wilson RF, Das GS. The development of porous alginate/elastin/PEG composite matrix for cardiovascular engineering. J. Biomater. Appl. 17, 287–301 (2003).
   PubMed Web of Science ®Google Scholar
• Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44, 654–660 (2004).
   PubMed Web of Science ®Google Scholar
• Stock UA, Mayer JE Jr. Tissue engineering of cardiac valves on the basis of PGA/PLA co-polymers. J. Long Term Eff. Med. Implants 11, 249–260 (2001).
   PubMedGoogle Scholar
• Pego AP, Siebum B, van Luyn MJ et al. Preparation of degradable porous structures based on 1,3-trimethylene carbonate and D,L-lactide (co)polymers for heart tissue engineering. Tissue Eng. 9, 981–994 (2003).
   PubMedGoogle Scholar
• Zammaretti P, Jaconi M. Cardiac tissue engineering: regeneration of the wounded heart. Curr. Opin. Biotechnol. 15, 430–434 (2004).
   PubMed Web of Science ®Google Scholar
• Leor J, Amsalem Y, Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther. 105, 151–163 (2005).
   PubMed Web of Science ®Google Scholar
• Calvillo L, Latini R, Kajstura J et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl Acad. Sci. USA 100, 4802–4806 (2003).
   PubMed Web of Science ®Google Scholar
• Takano H, Ohtsuka M, Akazawa H et al. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr. Pharm. Des. 9, 1121–1127 (2003).
   PubMed Web of Science ®Google Scholar
• Wang Y, Ahmad N, Wani MA, Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell. Cardiol. 37, 1041–1052 (2004).
   PubMed Web of Science ®Google Scholar
• Jayasankar V, Woo YJ, Bish LT et al. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108(Suppl. 1), II230–II236 (2003).
   PubMed Web of Science ®Google Scholar
• Musaro A, Giacinti C, Borsellino G et al. Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 101, 1206–1210 (2004).
   PubMed Web of Science ®Google Scholar
• Zou Y, Takano H, Mizukami M et al. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108, 748–753 (2003).
   PubMed Web of Science ®Google Scholar
• Hiasa K-i, Ishibashi M, Ohtani K et al. Gene transfer of stromal cell-derived factor-1{α} enhances Ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109, 2454–2461 (2004).
   PubMed Web of Science ®Google Scholar
• Bock-Marquette I, Saxena A, White MD, Michael Dimaio J, Srivastava D. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466–472 (2004).
   PubMed Web of Science ®Google Scholar
• Laguens R, Cabeza Meckert P, Vera Janavel G et al. Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer. Gene Ther. 9, 1676–1681 (2002).
   PubMed Web of Science ®Google Scholar